BidaskClub Lowers athenahealth (NASDAQ:ATHN) to Sell

BidaskClub lowered shares of athenahealth (NASDAQ:ATHN) from a hold rating to a sell rating in a research report released on Tuesday, January 16th.

A number of other brokerages also recently commented on ATHN. KeyCorp reiterated a buy rating and issued a $152.00 price objective on shares of athenahealth in a research report on Friday, January 12th. Wells Fargo & Co reduced their price objective on athenahealth from $190.00 to $155.00 and set an outperform rating for the company in a research report on Monday, October 23rd. Oppenheimer reiterated a buy rating and issued a $184.00 price objective on shares of athenahealth in a research report on Friday, October 20th. TheStreet downgraded athenahealth from a b- rating to a c+ rating in a research report on Wednesday, October 11th. Finally, First Analysis upgraded athenahealth from an underweight rating to an equal weight rating and raised their target price for the stock from $125.00 to $127.00 in a research report on Monday, October 23rd. Three research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and seven have issued a buy rating to the company. The company presently has a consensus rating of Hold and a consensus target price of $145.05.

athenahealth (NASDAQ:ATHN) traded up $3.80 on Tuesday, reaching $131.07. The company’s stock had a trading volume of 508,734 shares, compared to its average volume of 568,843. The firm has a market cap of $5,250.00, a price-to-earnings ratio of 100.82, a P/E/G ratio of 2.48 and a beta of 1.35. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.84 and a quick ratio of 1.84. athenahealth has a 12-month low of $95.01 and a 12-month high of $158.66.

athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.48. The firm had revenue of $329.20 million for the quarter, compared to analyst estimates of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The company’s revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.62 EPS. equities research analysts expect that athenahealth will post 2.29 EPS for the current year.

In other news, CEO Jonathan Bush sold 25,000 shares of athenahealth stock in a transaction on Monday, February 5th. The stock was sold at an average price of $145.00, for a total value of $3,625,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction on Monday, November 20th. The shares were sold at an average price of $130.00, for a total value of $104,000.00. The disclosure for this sale can be found here. Insiders sold a total of 98,703 shares of company stock valued at $13,487,150 over the last three months. Insiders own 3.20% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ATHN. American International Group Inc. acquired a new stake in shares of athenahealth during the fourth quarter worth $124,000. The Manufacturers Life Insurance Company grew its stake in shares of athenahealth by 7.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after purchasing an additional 84 shares during the period. BNP Paribas Arbitrage SA grew its stake in shares of athenahealth by 123.8% during the second quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock worth $189,000 after purchasing an additional 744 shares during the period. ProShare Advisors LLC acquired a new stake in shares of athenahealth during the second quarter worth $205,000. Finally, Ameriprise Financial Inc. acquired a new stake in shares of athenahealth during the second quarter worth $206,000.

TRADEMARK VIOLATION WARNING: “BidaskClub Lowers athenahealth (NASDAQ:ATHN) to Sell” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://ledgergazette.com/2018/02/12/athenahealth-athn-downgraded-by-bidaskclub-to-sell.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply